TY  - JOUR

T1  - Antisense oligonucleotide therapy in amyotrophic lateral sclerosis

JO  - Current Opinion in Neurology

UR  - https://doi.org/10.1097/wco.0000000000001413

PY  - 2025/08/20

AU  - Erdi-Krausz G

AU  - Shaw PJ

ED  - 

DO  - DOI: 10.1097/wco.0000000000001413

PB  - Ovid Technologies (Wolters Kluwer Health)

VL  - 38

IS  - 5

SP  - 574

EP  - 580

Y2  - 2025/10/28

ER  -